Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 17/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.45 |
| ▸ | PLA2G2E | Q9NZK7 | 3/20 | 0.45 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.45 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7007210 | 0.91 | PLA2G1B (0.53) | PLA2G1BPLA2G2APLA2G2EPLA2G5 | |
| SCHEMBL7012444 | 0.87 | PLA2G1B (0.46) | PLA2G1BPLA2G2APLA2G2EPLA2G5 | |
| SCHEMBL7014374 | 0.83 | PLA2G1B (0.57) | PLA2G1BPLA2G2APLA2G2EPLA2G5 | |
| SCHEMBL8615512 | 0.78 | PLA2G1B (0.43) | PLA2G1BPLA2G2APLA2G2EPLA2G5 | |
| SCHEMBL7013840 | 0.77 | PLA2G1B (0.47) | PLA2G1BPLA2G2APLA2G2EPLA2G5 | |
| SCHEMBL7013388 | 0.77 | PLA2G1B (0.48) | PLA2G1BPLA2G2A | |
| SCHEMBL7012614 | 0.77 | PLA2G1B (0.48) | PLA2G1BPLA2G2APLA2G2EPLA2G5 | |
| SCHEMBL8318865 | 0.76 | PLA2G1B (0.48) | PLA2G1BPLA2G2APLA2G2EPLA2G5PLA2G10 | |
| Butane SCHEMBL7011259 | 0.76 | PLA2G1B (0.41) | PLA2G1B | |
| SCHEMBL7013764 | 0.72 | PLA2G1B (0.58) | PLA2G1BPLA2G2APLA2G2EPLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998047507-A1 | METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 1998-10-29 | — | — | WO | disclosed |